单剂量Nevirapine母婴阻断与HIV耐药
Prevention of mother-to-child transmission with single dose Nevirapine and human immunodeficiency virus drug resistance
摘要
全球艾滋病的流行形势日趋严重，2007年15岁以下儿童感染者为250万，其中大部分是母婴传播，新感染人数为42万，死亡人数为33万，妇女艾滋病感染者为1540万。如果不接受抗病毒治疗，HIV感染儿童的预后很不乐观，大约有50％儿童在2周岁之前死亡。因此对HIV阳性孕妇及其婴儿实行母婴预防阻断措施，控制和降低儿童感染率，有着非常重要的现实意义。
出处
《中华流行病学杂志》
CAS
CSCD
北大核心
2008年第7期730-733,共4页
Chinese Journal of Epidemiology
参考文献26
-
12007 AIDS epidemic update[OL].http://data. unaids. org/pub/ EPISlides/2007/2007 _ eplupdate _ en. pdf.
-
2Ciuta ST, Boros S, Napoli PA, et al. Predictors of survival in children with acquired immuno-deficiency syndrome in Italy, 1983 to 1995. AIDS Patient Care STDS, 1998,12:629-637.
-
3Newell ML, Coovadla H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet, 2004,364 : 1236-1243.
-
4Connor EM,Sperling RS, Gelber R, et al. Reduction of maternalinfant transmission of human immunodeficiency virus type 1 with zidovudine treatment, Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med, 1994,331:1173-1180.
-
5Guay LA,Musoke P, Fleming T, et al. Intrapartum and neonatal slngle-dose nevirapine compared with zidovudlne for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet, 1999,354:795-802.
-
6Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet, 2003,362:859 -868.
-
7Taha TE,Kumwenda NI, Hoover DR, et al. Nevirapine and Zidovudine at birth to reduce perinatal transmission of HIV in an African setting. J Am Med Assoc, 2004,292 : 202-209.
-
8WHO reconfirms its support for the use of nevirapine to prevent mother-to-child transmission of HIV (July 2003 )[OL]. http:// www. who. int/hiv/pub/mtct/en/NevirapineStatement072003.pdf.
-
9Richman DD, Havlir D, Corbeil J, et al. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J Virol, 1994,68 : 1660-1666.
-
10Eshleman SH,Mracna M, Guay LA, et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV 1 vertical transmission( HIVNET 012). AIDS, 2001, 15:1951-1957.
-
1李莹,李文凡.乙型肝炎垂直传播及阻断措施的研究现状[J].中华传染病杂志,2006,24(2):130-132. 被引量：22
-
2杨国瑞.乙型肝炎母婴传播特点及阻断措施的临床应用分析[J].中国社区医师（医学专业）,2012,14(9):48-48. 被引量：2
-
3孙焕芹.16例儿童艾滋病病人的临床特点及护理[J].护理研究（下旬版）,2005,19(9):1934-1935. 被引量：2
-
4刘倩.HIV阳性孕妇母婴阻断的临床分析[J].河南外科学杂志,2012,18(6):28-29. 被引量：1
-
5周小葵.宜昌市预防艾滋病母婴传播情况分析[J].中国皮肤性病学杂志,2009,23(3):165-166. 被引量：11
-
6龙骏,周安蝉,吴亚丽,何应中.乙型肝炎母婴传播特点及阻断措施的临床探讨(附63例分析)[J].遵义医学院学报,2004,27(2):151-152. 被引量：2
-
7朱伟光.一起HIV职业暴露的调查处理[J].江苏预防医学,2007,18(2):69-70. 被引量：2
-
8彭红梅,韩玉明.喀什地区妊娠妇女HIV感染情况调查分析[J].检验医学与临床,2013,10(5):613-613. 被引量：1
-
9魏尊.咸宁市3例HIV阳性孕妇的调查报告[J].中国艾滋病性病,2007,13(1):61-61.
-
10SusanE.Scarrow,曹冬焱.HIV阳性孕妇的分娩方式：法律和伦理方面的考虑[J].世界医学杂志,2002,6(5):43-45.
